Strategic ConsiderationsFurther Development of the Rhine-Neckar Health and Life Science Region

9 October 2020

Leading representatives from science, research and healthcare present key points of a strategy paper

Strategic considerations on further developing the Rhine-Neckar Health and Life Science Region were the focus of a press conference which took place in Mannheim on 9 October 2020. Together, leading representatives of science, research and healthcare from Heidelberg and Mannheim presented the key points of a strategy paper to the Baden-Württemberg Science Ministry and the public at large.

Panelists:

Prof. Dr Ingo Autenrieth
Chairman of the Board and Chief Medical Director of Heidelberg University Hospital

Prof. Dr Michael Baumann
Chairman of the Management Board and Scientific Director of the German Cancer Research Center, Heidelberg

Freddy Bergmann
Commercial Manager of the University Hospital Mannheim

Prof. Dr Bernhard Eitel
Rector of Heidelberg University

Katrin Erk
Deputy Chairman and Administrative Director of Heidelberg University Hospital

Prof. Dr Sergij Goerdt
Dean of the Medical Faculty Mannheim of Heidelberg University

Prof. Dr Hans-Jürgen Hennes
Executive Board Chair and Medical Director of the University Hospital Mannheim

Dr Jan Korbel
Head of Data Science at the European Molecular Biolology Laboratory (EMBL) in Heidelberg and Co-Director of the Molecular Medicine Partnership Unit of the Medical Faculty Heidelberg and EMBL

Prof. Dr Hans-Georg Kräusslich
Dean of the Medical Faculty Heidelberg of Heidelberg University

Dr Peter Kurz
Lord Mayor of the City of Mannheim and Chair of the Supervisory Board of the University Hospital Mannheim

Prof. Dr Andreas Meyer-Lindenberg
Director of the Central Institute of Mental Health, Mannheim

Prof. Dr Joachim Spatz
Director of the Max Planck Institute for Medical Research, Heidelberg

The main considerations of the strategy paper can be accessed at:

Heidelberg Mannheim Health and Life Science Alliance (PDF)